Kathi Niffenegger
2013
In 2013, Kathi Niffenegger earned a total compensation of $203.7K as Chief Financial Officer and Corporate Secretary at Edesa Biotech.
Compensation breakdown
| Option Awards | $55,201 |
|---|---|
| Salary | $137,500 |
| Other | $10,957 |
| Total | $203,658 |
Niffenegger received $137.5K in salary, accounting for 68% of the total pay in 2013.
Niffenegger also received $55.2K in option awards and $11K in other compensation.
Rankings
In 2013, Kathi Niffenegger's compensation ranked 11,579th out of 12,286 executives tracked by ExecPay. In other words, Niffenegger earned more than 5.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,579 out of 12,286 | 6th |
Division Manufacturing | 4,345 out of 4,612 | 6th |
Major group Chemicals And Allied Products | 1,380 out of 1,466 | 6th |
Industry group Drugs | 1,096 out of 1,160 | 6th |
Industry Pharmaceutical Preparations | 844 out of 890 | 5th |
Source: SEC filing on January 25, 2016.
Niffenegger's colleagues
We found three more compensation records of executives who worked with Kathi Niffenegger at Edesa Biotech in 2013.
News
Edesa Biotech CEO Pardeep Nijhawan's 2023 pay slips 9% to $550K
April 5, 2024
Edesa Biotech CEO Pardeep Nijhawan's 2022 pay falls 54% to $602K
March 28, 2023
Edesa Biotech CEO Pardeep Nijhawan's 2021 pay jumps 221% to $1.3M
April 1, 2022
Edesa Biotech President Michael Brooks' 2020 pay jumps 155% to $529K
March 3, 2021
Edesa Biotech President Michael Brooks' 2019 pay slips 10% to $207K
March 23, 2020